Wal-Mart (WMT) PT Raised to $79 at Stifel Following 1Q

Bullish Options Activity in Wal-Mart (WMT) Post Earnings Announcement -Susquehanna

May 19, 2017 2:34 PM EDT

Susquehanna options strategists Alison Edwards notes bullish options activity in Wal-mart (NYSE: WMT) following the company's earnings announcement, as opening investors bought 10,000 JunQ 79.5 Calls paying about $1.07 up to $1.50

... More

Wal-Mart (WMT) PT Raised to $80 at UBS; Remains Neutral

May 19, 2017 10:57 AM EDT

UBS raised its price target on Wal-Mart (NYSE: WMT) to $80.00 (from $73.00) while maintaining a Neutral rating. WMT reported a 1.4% increase in 1Q revenue to $117.5 bn, with net sales up 1.3% to $116.5 bn.

WMT's guidance implies ~10 bps of OM contraction next Q. Analyst... More

Wal-Mart (WMT) PT Raised to $80 at UBS on 1Q Report; 'Expect Top-Line Momentum to Continue'

May 19, 2017 10:40 AM EDT

UBS raised its price target on Wal-Mart (NYSE: WMT) to $80.00 (from $73.00) while maintaining a Neutral rating, following the company's first quarter earnings report.

Analyst Micahel Lasser notes the company delivered earnings per share figures and U.S. traffic growth above consensus expectations due... More

BMO Capital Upgrades Wal-Mart (WMT) to Market Perform

May 19, 2017 6:12 AM EDT

BMO Capital upgraded Wal-Mart (NYSE: WMT) from Underperform to Market Perform with a price target of $80.00 (from $63.00).

For an analyst ratings summary and ratings history on Wal-Mart click here. For more ratings news on Wal-Mart click here.

Shares of Wal-Mart closed at $77.54 yesterday.

... More

Wal-Mart (WMT) PT Raised to $76 at Buckingham Research Following 1Q Report; 'Most Metrics Moving in Right Direction'

May 18, 2017 12:54 PM EDT

Buckingham Research raised its price target on Wal-Mart (NYSE: WMT) to $76.00 (from $73.00) while maintaining a Neutral rating, following the company's first quarter operating results.

Analyst John Zolidis notes the company delivered earnings per share above consensus with comps in-line with guidance,... More

Pre-Open Movers 05/18: (GLYC ) (ATHN) (PLCE) Higher; (ASNA) (SMRT) (MEET) Lower (more...)

May 18, 2017 9:35 AM EDT

Today's Pre-Open Movers:

GlycoMimetics, Inc. (NASDAQ: GLYC) 37.4% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for treatment of adult relapsed/refractory acute myeloid leukemia (AML) to the companys drug candidate GMI-1271, an E-selectin antagonist currently being evaluated in the Phase 2 portion of a Phase 1/2 clinical trial in patients with AML. The U.S. Food and Drug Administration (FDA) had previously granted Orphan Drug designation and Fast Track Status for GMI-1271 in AML.

ascena retail... More

Wal-mart (WMT) Tops Q1 EPS by 4c, U.S. Comps Increase 1.4%

May 18, 2017 7:04 AM EDT

Wal-mart (NYSE: WMT) reported Q1 EPS of $1.00, $0.04 better than the analyst estimate of $0.96. Revenue for the quarter came in at $117.5 billion versus the consensus estimate of $117.74 billion.

Walmart U.S. comp sales increased 1.4%, driven by a traffic increase of 1.5%. Comp traffic increased 3.0% on... More

Germany's Lidl to price groceries up to 50 percent below U.S. rivals

May 17, 2017 12:06 PM EDT

By Nandita Bose

NEW YORK (Reuters) - German discount grocery chain Lidl, which is opening its first U.S. stores this summer, said its products would be up to 50 percent cheaper than competitors, which are already caught up in a price war.

"This is the right time for us to enter the United States," Brendan Proctor, chief executive officer for Lidl U.S., told Reuters at a... More

Target optimistic on full-year forecast after profit beat

May 17, 2017 6:43 AM EDT

By Sruthi Ramakrishnan and Siddharth Cavale

(Reuters) - Target Corp (NYSE: TGT) reported higher-than-expected quarterly profit and sales and set an optimistic tone for the year, saying its full-year profit could come in at the higher end of its forecast.

Target's shares rose 3 percent on Wednesday as the outlook allayed some investor concerns following the company's warning just three months ago that its full-year targets were too high.

The company has been trying to turn around its business for several years and in February vowed to aggressively promote its... More